ATE46155T1 - Fluorcumarine als antilymphoedema-mittel. - Google Patents

Fluorcumarine als antilymphoedema-mittel.

Info

Publication number
ATE46155T1
ATE46155T1 AT85115883T AT85115883T ATE46155T1 AT E46155 T1 ATE46155 T1 AT E46155T1 AT 85115883 T AT85115883 T AT 85115883T AT 85115883 T AT85115883 T AT 85115883T AT E46155 T1 ATE46155 T1 AT E46155T1
Authority
AT
Austria
Prior art keywords
sub
hydrogen
fluorine
agent
fluorcumarine
Prior art date
Application number
AT85115883T
Other languages
English (en)
Inventor
Carmelo A Gandolfi
Odoardo Tofanetti
Silvano Spinelli
Piervitto Cipolla
Sergio Tognella
Original Assignee
Boehringer Biochemia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Biochemia Srl filed Critical Boehringer Biochemia Srl
Application granted granted Critical
Publication of ATE46155T1 publication Critical patent/ATE46155T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
AT85115883T 1984-12-21 1985-12-12 Fluorcumarine als antilymphoedema-mittel. ATE46155T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB08432464A GB2168696B (en) 1984-12-21 1984-12-21 Fluoro coumarins as antilymphoedema agents
EP85115883A EP0185319B1 (de) 1984-12-21 1985-12-12 Fluorcumarine als Antilymphoedema-Mittel

Publications (1)

Publication Number Publication Date
ATE46155T1 true ATE46155T1 (de) 1989-09-15

Family

ID=10571633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85115883T ATE46155T1 (de) 1984-12-21 1985-12-12 Fluorcumarine als antilymphoedema-mittel.

Country Status (7)

Country Link
US (1) US4749798A (de)
EP (1) EP0185319B1 (de)
JP (1) JPS61180781A (de)
AT (1) ATE46155T1 (de)
AU (1) AU599893B2 (de)
DE (1) DE3572812D1 (de)
GB (1) GB2168696B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278186A (en) * 1990-02-10 1994-01-11 Takeda Chemical Industries, Ltd. Chromene derivatives, their production and use
DE4111861A1 (de) * 1991-04-11 1992-10-15 Schwabe Willmar Gmbh & Co Benzopyranone, verfahren zu ihrer herstellung und verwendung
US6124477A (en) * 1996-06-27 2000-09-26 Bioavailability Systems, Llc Anti-first-pass effect compounds
US5830912A (en) * 1996-11-15 1998-11-03 Molecular Probes, Inc. Derivatives of 6,8-difluoro-7-hydroxycoumarin
CA2284525A1 (en) * 1997-04-16 1998-10-22 The University Of New Mexico Inhibitors of cholesterol esterase
US6248776B1 (en) 1997-08-26 2001-06-19 Bioavailability Systems, L.L.C. Anti-first-pass effect compounds
ES2199457T3 (es) * 1997-08-26 2004-02-16 Bioavailability Systems, L.L.C. Compuestos que inhiben el efecto del primer paso.
ES2249391T3 (es) * 2001-12-04 2006-04-01 MAC PHARMA S.A.S. DI PAOLA MICHIELETTO & C. Uso de cumarina o su derivado hidroxilado para el tratamniento del edema vascular y/o linfatico medio o grave.
US20070298132A1 (en) * 2002-05-03 2007-12-27 Pharmchem Inc. Berberine as a selective lung cancer agent
CA2595472A1 (en) 2005-01-21 2006-07-27 Janssen Pharmaceutica N.V. Novel coumarin derivatives as ion channel openers
JP5404652B2 (ja) 2008-02-22 2014-02-05 アクテリオン ファーマシューティカルズ リミテッド オキサゾリジノン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110848A (en) * 1965-06-18 1968-04-24 Stauffer Chemical Co Control of growth of fungi and bacteria
BE788200A (fr) * 1971-09-03 1973-02-28 Lonza Ag Procede de fabrication de 4-halogenomethylcoumarines et nouveaux composes ainsi obtenus
US4701456A (en) * 1984-09-19 1987-10-20 Warner-Lambert Company Aminoalkoxybenzopyranones as antipsychotic and anxiolytic agents

Also Published As

Publication number Publication date
JPS61180781A (ja) 1986-08-13
GB2168696A (en) 1986-06-25
GB8432464D0 (en) 1985-02-06
EP0185319A3 (en) 1987-04-29
EP0185319A2 (de) 1986-06-25
AU599893B2 (en) 1990-08-02
AU5154985A (en) 1986-06-26
EP0185319B1 (de) 1989-09-06
DE3572812D1 (en) 1989-10-12
GB2168696B (en) 1989-01-11
US4749798A (en) 1988-06-07

Similar Documents

Publication Publication Date Title
ES467494A1 (es) Procedimiento para preparar derivados de fenoxibenciloxicar-bonilo.
ES481220A1 (es) Un procedimiento para la preparacion de 2-aril-aminotiazo- les.
NO931793L (no) Polyazamakrocykliske forbindelser for metallionkompleksdannelse
FR2372219A1 (fr) Compositions anti-solaires
DE3572812D1 (en) Fluoro coumarins as antilymphoedema agents
ES8707525A1 (es) Un procedimiento para la preparacion de nuevas isoindolinil-alquilpiperazinas
SE7610038L (sv) Miticida och aficida karboxylsyraestrar
KR860700250A (ko) 신규 아미딘 화합물
ATE50773T1 (de) Alkylresorcinolphosphite.
DE3572816D1 (de) Pyridazinone inotropic agents
ES8705421A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
BR8504501A (pt) Composto acaricida,processo para sua producao,composicao acaricida e processo para combater acaros
FI914525A0 (fi) Foerening, anvaendning och framstaellning.
EP0180643A4 (de) Fluoranverbindungen.
ES8301931A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
TR21566A (tr) Substituee pirimidinil organofosfor ensektisidler
BR8406121A (pt) Composto inseticida,composicao inseticida e processo para combater insetos prejudiciais
AR009934A1 (es) Compuesto fungicida arilacrilico, composicion fungicida que lo contiene y metodos de uso y sintesis
ES8501408A1 (es) Procedimiento para la preparacion de agentes biocidas
FI852249A0 (fi) Foerfarande foer framstaellning av nya isoxazolokinolinoner.
ES8504781A1 (es) Procedimiento de preparacion de nuevos uracilos sustituidos en 1 por un grupo feniloxicarbonilo sustituido.
ES8602825A1 (es) Un procedimiento para preparar un compuesto fosforoditioico
ES8201157A1 (es) Procedimiento para la preparacion de nuevos imidazoles subs-tituidos
FI863639A0 (fi) Foerfarande foer framstaellning av brom-fluoraettiksyror.
ATE37531T1 (de) Bestimmte 2-(2-substituierte benzoyl)-1,3cyclohexandione.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties